AlphaYou
Overview
Smart money at a glance
Filings to Oct 2, 2026Net selling: insiders sold $2.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$2.3M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 8 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 1- Open
- $32.31
- 52-wk high
- $47.86
- High
- $32.69
- 52-wk low
- $26.71
- Low
- $32.09
- Prev close
- $32.24
- Mkt cap
- $5.47B
- P/E
- 9.7x
- Volume
- 1.88M
- Fwd P/E
- 18.3x
- Beta
- 0.58
- Div yield
- 2.22%
- P/S
- 1.0x
- P/B
- 2.2x
- Profit margin
- +11.1%
- Op margin
- +15.0%
- ROE
- +22.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about G filings
Are insiders buying or selling Genpact Limited (G) stock?
Net selling: insiders sold $2.3M and bought $0 of G stock on the open market in the 90 days to Oct 2, 2026, according to SEC Form 4 filings. The largest was Nanduru, Anil (Senior Vice President), who sold $1.2M. The latest filing was on Sep 16, 2026.
Which members of Congress have traded G recently?
None. No member of Congress disclosed a G trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this G smart-money data?
This summary uses filings available on Oct 2, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- CI
Citadel
$64.0M
added
- TS
Two Sigma
$40.7M
added
- QR
Qube Research
$34.1M
bought
What insiders are doing
How top traders are positioned
No tracked top-trader positions in G right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 4.7% above what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.85 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $0.89 / $0.85Alpha Vantage | +4.71% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $0.98 / $0.92Alpha Vantage | +6.52% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 5, 2026 | $0.97 / $0.93Alpha Vantage | +4.30% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $0.97 / $0.90Alpha Vantage | +7.78% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $0.76 / $0.75Alpha Vantage | +1.33% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 7, 2025 | $0.84 / $0.79Alpha Vantage | +6.33% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 6, 2025 | $0.91 / $0.86Alpha Vantage | +5.81% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | $0.85 / $0.80Alpha Vantage | +6.25% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 5, 2026, in 34 days
Estimates as of Sep 28, 2026
EPS expected
$1.04 to $1.06
Revenue expected
10 analysts
Last 30 days
Analysts cutting estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.29B | $1.32B | $1.30B | $1.34B |
| Cost of what it sold | $821.6M | $837.0M | $818.1M | $853.1M |
| Gross profit | $469.7M | $482.3M | $478.2M | $490.3M |
| What it spent | ||||
| Sales and admin | $262.1M | $277.1M | $270.3M | $294.1M |
| Other operating costs | $15.9M | $7.4M | — | $3.3M |
| Total operating expenses | $278.0M | $284.5M | $269.0M | $297.4M |
| What was left | ||||
| Operating profit | $191.6M | $197.8M | $209.2M | $192.9M |
| Interest on debt | $17.8M | $19.9M | $21.3M | $19.9M |
| Profit before tax | $189.4M | $188.8M | $194.0M | $190.9M |
| Tax | $43.5M | $45.7M | $46.0M | $45.1M |
| Net profit | $145.8M | $143.1M | $148.0M | $145.7M |
| EBITDA | $229.4M | $226.7M | $201.0M | $232.3M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Genpact Limited (G) stock price, news, quote and history
NeutralSep 23Genpact Limited (G) latest stock news and headlines – Yahoo Finance
Leans bullishSep 22Genpact (NYSE: G) details pay and limits for its departing CFO
NeutralSep 19Genpact (NYSE: G) insider plans $368K stock sale
NeutralSep 18Genpact (NYSE: G) CEO sells 10,000 shares, keeps 501,114
BearishSep 18Genpact (NYSE: G) plans Delaware switch—what changes for shareholders?
NeutralSep 18